Aeglea Biotherapeutics, INC.

Clinical-stage biotechnology company; designs and develops human enzyme therapeutics

Based in TX

🤖

AI Overview

With $330K in lobbying spend across 13 quarterly filings, Aeglea Biotherapeutics, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2023.

$330K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2020	$80K
2021	$120K
2022	$100K
2023	$30K

Issues Lobbied

Pharmacy Health Issues

Lobbying Firms

The Kpm Group DC LLC

Lobbyists

Patroski Lawson Benjamin Mason Katherine Landes Jacob Jackson

Government Agencies Targeted

These are the government entities that Aeglea Biotherapeutics, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues

Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) engagement

Meetings on Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) Engagement

H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019

S.4010/H.R. 4439 - Creating Hope Reauthorization Act

Drug pricing

H.R. 1730/S. 670, STAT Act

H.R. 482/S. 350, Newborn Screening Reauthorization Act

Cures 2.0 (not introduced)